246
Participants
Start Date
September 24, 2015
Primary Completion Date
July 14, 2017
Study Completion Date
January 17, 2018
Pegcetacoplan
Sham Procedure
Auckland Eye, Remuera
Save Sight Institute, Sydney Eye Hospital, Sydney
Sydney Retina Clinic and Day Surgery, Sydney
Sydney West Retina, Westmead
Marsden Eye Specialists, Paramatta
Royal Victorian Eye and Ear Hospital, East Melbourne
Center for Eye Research Australia, Melbourne
Lions Eye Institute, Nedlands
Hobart eye Surgeons, Hobart
Tasmanian Eye Institute, South Launceston
Southern Eye Specialists, Merivale
Vitreous Retina Macula Consultants of New York, New York
Mid Atlantic, Philadelphia
Elman Research, Baltimore
Duke University, Duke Eye Center, Durham
Charlotte Eye Ear Nose and Throat Associates, Charlotte
Charlotte Eye Ear Nose and Throat Associates, Statesville
South East Retina, Augusta
Bascom Palmer Eye Institute, Miami
Florida Eye Microsurgical Institute, Inc., Boynton Beach
Retina Health Center, Fort Myers
Retina Speciality Institute, Mobile
Tennessee Retina, PC, Nashville
Cleveland Clinic Foundation/ Cole Eye Institute, Cleveland
Retina Associates of Cleveland, Cleveland
Associated Retinal Consultants PC, Grand Rapids
Midwest Eye Institute, Indianapolis
Associated Retinal Consultants, PC, Traverse City
Mayo Clinic, Rochester
Black Hills Regional Eye Institute, Rapid City
Illinois Retina Associates, Harvey
Retina Specialists, Plano
Valley Retina Institute, PA, McAllen
Retina Consultants of Houston, Houston
Retina Consultants of Houston (The Woodlands), The Woodlands
Retina Research Center, Austin
Retina Research Institute of Texas, Abilene
University of Utah, Salt Lake City
Retinal Research Institute, Phoenix
University of Southern California - USC Eye Institute, Los Angeles
Retina Vitreous Asociates Mdical Goup, Beverly Hills
The Gavin Herbert Eye Institute/UC Irvine, Irvine
Byers Eye Institute at Stanford, Stanford School of Medicine, Palo Alto
New England Retina Associates, New London
Ophthalmic Consultants of Boston, Boston
Eyesight Opthalmic Services PA, Portsmouth
Lead Sponsor
Apellis Pharmaceuticals, Inc.
INDUSTRY